182 related articles for article (PubMed ID: 25975416)
1. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
[TBL] [Abstract][Full Text] [Related]
2. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer.
Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
[TBL] [Abstract][Full Text] [Related]
4. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
[TBL] [Abstract][Full Text] [Related]
5. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.
Chen ZY; Raghav K; Lieu CH; Jiang ZQ; Eng C; Vauthey JN; Chang GJ; Qiao W; Morris J; Hong D; Hoff P; Tran H; Menter DG; Heymach J; Overman M; Kopetz S
Br J Cancer; 2015 Mar; 112(6):1088-97. PubMed ID: 25688736
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
[TBL] [Abstract][Full Text] [Related]
8. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
[TBL] [Abstract][Full Text] [Related]
9. Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.
Bortolin MT; Tedeschi R; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
Cytokine; 2012 Oct; 60(1):90-5. PubMed ID: 22795293
[TBL] [Abstract][Full Text] [Related]
10. Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies.
Patel GS; Ullah S; Beeke C; Hakendorf P; Padbury R; Price TJ; Karapetis CS
Cancer Med; 2015 Oct; 4(10):1461-71. PubMed ID: 26211512
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.
Spindler KL; Appelt AL; Pallisgaard N; Andersen RF; Brandslund I; Jakobsen A
Int J Cancer; 2014 Dec; 135(12):2984-91. PubMed ID: 24798213
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
Jary M; Lecomte T; Bouché O; Kim S; Dobi E; Queiroz L; Ghiringhelli F; Etienne H; Léger J; Godet Y; Balland J; Lakkis Z; Adotevi O; Bonnetain F; Borg C; Vernerey D
Int J Cancer; 2016 Nov; 139(10):2325-35. PubMed ID: 27472156
[TBL] [Abstract][Full Text] [Related]
13. High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab.
Zhu L; Liu B; Zhao Y; Liu L; Yang C; Yang Y; Zhong H
J Cancer Res Ther; 2014 Dec; 10 Suppl():246-51. PubMed ID: 25693928
[TBL] [Abstract][Full Text] [Related]
14. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
Golan T; Urban D; Berger R; Lawrence YR
Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
[TBL] [Abstract][Full Text] [Related]
15. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
16. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy.
Liu YL; Xu HT; Jiang SX; Yang YM; Cui BB
J Surg Oncol; 2014 Mar; 109(3):234-8. PubMed ID: 24449194
[TBL] [Abstract][Full Text] [Related]
18. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
[TBL] [Abstract][Full Text] [Related]
19. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.
Xie QK; Chen P; Hu WM; Sun P; He WZ; Jiang C; Kong PF; Liu SS; Chen HT; Yang YZ; Wang D; Yang L; Xia LP
J Transl Med; 2018 Oct; 16(1):273. PubMed ID: 30286769
[TBL] [Abstract][Full Text] [Related]
20. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]